The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology

被引:110
作者
Balen, A [1 ]
机构
[1] Gen Infirm, Dept Reprod Med, Leeds LS2 9NS, W Yorkshire, England
关键词
hyperandrogenism; insulin resistance; luteinising hormone; polycystic ovary syndrome;
D O I
10.1016/j.bpobgyn.2004.05.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The pathophysiology of the polycystic ovary syndrome (PCOS) encompasses inherent ovarian dysfunction that is strongly influenced by external factors, such as disturbances of the hypothalamic-pituitary-ovarian axis and hyperinsulinaemia. Exaggerated gonadotrophin releasing hormone (GnRH) pulsatility results in hypersecretion of luteinising hormone (LH), which has effects both on ovarian androgen production and oocyte development. Disturbed ovarian-pituitary and hypothalamic feedback accentuates the 0gonadotrophin abnormalities. Hyperinsulinaemia is secondary both to insulin resistance at the periphery and to abnormal pancreatic beta cell function. PCOS runs in families and a number of genetic abnormalities appear to result in features of the syndrome and account for the heterogeneity of the symptoms. Environmental influences, such as nutrition and lifestyle, further influence expression of the syndrome.
引用
收藏
页码:685 / 706
页数:22
相关论文
共 124 条
[1]   GONADOTROPIN CONTROL OF FOLLICULAR DEVELOPMENT [J].
ABDULWAHID, NA ;
ADAMS, J ;
VANDERSPUY, ZM ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1985, 23 (06) :613-626
[2]   INSULIN ENHANCEMENT OF LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING-HORMONE RELEASE BY CULTURED PITUITARY-CELLS [J].
ADASHI, EY ;
HSUEH, AJW ;
YEN, SSC .
ENDOCRINOLOGY, 1981, 108 (04) :1441-1449
[3]  
ADASHI EY, 1993, ANN NY ACAD SCI, V687, P10
[4]   PRIMING EFFECT OF LUTEINIZING-HORMONE RELEASING FACTOR ON ANTERIOR-PITUITARY GLAND IN FEMALE RAT [J].
AIYER, MS ;
CHIAPPA, SA ;
FINK, G .
JOURNAL OF ENDOCRINOLOGY, 1974, 62 (03) :573-588
[5]   Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation [J].
Anderson, RA ;
Groome, NP ;
Baird, DT .
CLINICAL ENDOCRINOLOGY, 1998, 48 (05) :577-584
[6]  
ANTTILA L, 1991, FERTIL STERIL, V55, P1057
[7]   Body mass index and metabolic risk factors for coronary heart disease in women [J].
Ashton, WD ;
Nanchahal, K ;
Wood, DA .
EUROPEAN HEART JOURNAL, 2001, 22 (01) :46-55
[8]   PITUITARY-OVARIAN RELATIONSHIPS IN POLYCYSTIC OVARY SYNDROME [J].
BAIRD, DT ;
CORKER, CS ;
DAVIDSON, DW ;
HUNTER, WM ;
MICHIE, EA ;
VANLOOK, PF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (04) :798-809
[9]   What is polycystic ovary syndrome? Are national views important? [J].
Balen, A ;
Michelmore, K .
HUMAN REPRODUCTION, 2002, 17 (09) :2219-2227
[10]   Pathogenesis of polycystic ovary syndrome - the enigma unravels? [J].
Balen, A .
LANCET, 1999, 354 (9183) :966-967